default author photo

Christian U. Blank

Netherlands Cancer Institute

SCHOLARLY PAPERS

3

DOWNLOADS

113

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Real-World Outcomes with Ipilimumab and Nivolumab in Advanced Melanoma: A Multicentre Retrospective Study

Number of pages: 20 Posted: 31 Mar 2022
Patricio Serra-Bellver, Judith M. Versluis, Honey K. Oberoi, Cong Zhou, Timothy D. Slattery, Yasir Khan, James R. Patrinely, Ines Pires da Silva, Clara Martinez-Vila, Natalie Cook, Donna Graham, Matteo Carlino, Alexander M. Menzies, Ana M. Arance, Douglas B. Douglas, Georgina V. Long, Lisa Pickering, James M. G. Larkin, Christian U. Blank and Paul Lorigan
Manchester Academic Health Sciences Centre - The Christie NHS Foundation Trust, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, The University of Sydney - Melanoma Institute Australia, affiliation not provided to SSRN, The University of Manchester, The Christie NHS Foundation Trust, Blacktown Hospital, The University of Sydney - Melanoma Institute Australia, Hospital of Barcelona, Vanderbilt University - Vanderbilt-Ingram Cancer Center, The University of Sydney - Melanoma Institute Australia, Royal Marsden NHS Foundation Trust - Renal and Skin Units, NHS Foundation Trust - Royal Marsden Hospital, Netherlands Cancer Institute and The University of Manchester
Downloads 43 (1,145,425)

Abstract:

Loading...

melanoma, real-world, ipilimumab+nivolumab, immunotherapy

2.

Population Mortality in Advanced Melanoma Patients with and Without Response and Progression; Data from the Dutch Melanoma Treatment Registry

Number of pages: 20 Posted: 23 Nov 2022
Jesper van Breeschoten, Alfons J.M. van den Eertwegh, Doranne L. Hilarius, John Haanen, Christian U. Blank, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Djura P. Piersma, Rozemarijn S. van Rijn, Marion A. Stevense-den Boer, Gerard Vreugdenhil, Marye J. Boers-Sonderen, Damjan Manevski, Karijn P.M. Suijkerbuijk, Michel W.J.M. Wouters and Liesbeth C. de Wreede
Dutch Institute for Clinical Auditing, VU University Amsterdam - Department of Medical Oncology, Rode Kruis Ziekenhuis, Netherlands Cancer Institute - Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Maastricht University Medical Centre, Zuyderland Medical Centre, Isala Zwolle, University of Groningen - University Medical Center Groningen, Leiden University Medical Centre, Medisch Spectrum Twente, Medical Center Leeuwarden, Amphia Hospital, Maxima Medical Centre, Radboud University Nijmegen - Radboud University Medical Center, University of Ljubljana, Utrecht University - University Medical Center (Utrecht), Dutch Institute for Clinical Auditing and Leiden University - Leiden University Medical Center (LUMC)
Downloads 36 (1,236,159)

Abstract:

Loading...

relative survival, advanced melanoma, population mortality, older patients, response status, multi-state model

3.

The Impact of Neo-Adjuvant Versus Adjuvant Immune Checkpoint Inhibitors on Long-Term Health-Related Quality of Life in Stage Iii Patients with Melanoma

Number of pages: 23 Posted: 18 Apr 2025
Elaine Albers, M.J. Luijendijk, M. Egeler, I. Fraterman, M.W. Lucas, Kelly M. de Ligt, Sanne Schagen, Christian U. Blank and L.V. van de Poll-Franse
Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute - Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute and Netherlands Cancer Institute
Downloads 34 (1,263,436)

Abstract:

Loading...

Melanoma, immune checkpoint inhibition, health-related quality of life, neoadjuvant